<qa>  What is the overall response rate in Solid Tumors?I. To evaluate the Response Evaluation Criteria in Solid Tumors RECIST version v1.1 overall response rate ORR in subsets of patients with advanced rare cancers treated with ipilimumab plus nivolumab combination immunotherapy. 